Source: Stem Cell Therapeutics Corp.
Posted: May 11, 2006 8:30 am ET
Summary:
Stem Cell Therapeutics Corp. announced the issuance of its second U.S. patent entitled "Production of Radial Glial Cells", which protects novel methods of producing radial glial cells in the brain. The production of radial glial cells in the brain of a patient suffering from a central nervous system (CNS) disease has the potential to be a fundamental technology in the field, key to the successful development of neural stem cell based approaches for the treatment of many CNS diseases. CNS diseases possibly affected by successful implementation of this technology include stroke, acute brain injury, Alzheimer's disease, Multiple Sclerosis, Huntington's disease, Amyotrophic Lateral Sclerosis, and Parkinson's disease.
Commentary: Hopefully this patent will provide new guidelines, strategies and ideas to scientists and biotechnology firms about how to transform stem cells into effective treatments for human diseases.
No comments:
Post a Comment